Biomarkers and Enzymes for Heart Disease

The term biomarker means "measurable and quantifiable biological parameters (eg, specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) qui serve as clues for health- and physiology-related assessments, Such As disease risk, psychiatric disorders, environmental exposure and Its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.

Biomarkers can indicate indication a variety of health or disease characteristics, including the level or the type of exposure to an environmental factor, genetic susceptibility, genetic responses to exposures, markers of subclinical or clinical disease, or indicators of response to therapy.

  • Troponin test
  • Creatine kinase (CK-MB) test
  • Lactate dehydrogenase(LDH)
  • Aspartate transaminase(AST)
  • Myoglobin (Mb)
  • Ischemia-modified albumin (IMA)
  • Pro-brain natriuretic peptide
  • Glycogen phosphorylase isoenzyme BB

Related Conference of Biomarkers and Enzymes for Heart Disease

October 20-21, 2026

15th World Heart Congress

London, UK
November 09-10, 2026

7th Annual Summit on Cardiology and Heart Diseases

Paris, France
November 16-17, 2026

8th World Heart Congress

Tokyo, Japan
November 23-24, 2026

40th World Congress on Heart Diseases

Toronto, Canada
November 25-26, 2026

33rd World Heartcare Summit

Paris, France
January 26-27, 2027

12th International Heart Conference

Dubai, UAE
March 18-19, 2027

16th World Heart Congress

Paris, France
May 13-14, 2027

10th Annual Heart Rhythm Conference

Rome, Italy
June 17-18, 2027

10th World Heart and Brain Conference

London, UK
June 21-22, 2027

8th European Summit on Cardiology Research

Zurich, Switzerland

Biomarkers and Enzymes for Heart Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in